Please sign in to follow a disease.
Multiple endocrine neoplasia type 2
MONDO:0019003Multiple endocrine neoplasia type 2 (MEN2) is a multiple endocrine neoplasia, a polyglandular cancer syndrome characterized by the occurrence of medullary thyroid carcinoma (MTC), pheochromocytoma (PCC), in one variant, primary hyperparathyroidism (PHPT). There are three forms: MEN2A, MEN2B, and familial medullary thyroid carcinoma (FMTC).
Also known as: MEN2, multiple endocrine neoplasia type 2
2808 clinical trials for this condition and its sub-types, 4 tagged with Multiple endocrine neoplasia type 2 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Multiple endocrine neoplasia type 2
-
Familial medullary thyroid carcinoma 23 trials
-
Multiple endocrine neoplasia type 2A 4 trials
-
Multiple endocrine neoplasia type 2B 2 trials
-
Can Full-Body scans spot cancer early in High-Risk families?
Diagnosis OngoingThis study is testing whether whole body MRI scans can help find cancers early in children and adults with Li-Fraumeni syndrome, a genetic condition that greatly raises cancer risk. About 150 participants will receive annual whole body MRI scans for four years to see if they keep…
Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Researchers launch registry to track rare endocrine tumors
Knowledge-focused OngoingThis study gathers health questionnaires from up to 1,500 people with multiple endocrine neoplasia (MEN1 or MEN2) and their close relatives. The goal is to build a database that helps researchers better understand these rare inherited conditions. No new treatments or procedures a…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC